Kestra Advisory Services’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,697
| Closed | -$160K | – | 2817 |
|
|
2025
Q1 | $160K | Sell |
7,697
-951
| -11% | -$19.7K | ﹤0.01% | 2524 |
|
|
2024
Q4 | $204K | Sell |
8,648
-3,229
| -27% | -$76K | ﹤0.01% | 2463 |
|
|
2024
Q3 | $304K | Sell |
11,877
-1,650
| -12% | -$42.2K | ﹤0.01% | 2073 |
|
|
2024
Q2 | $318K | Sell |
13,527
-4,191
| -24% | -$98.4K | ﹤0.01% | 2074 |
|
|
2024
Q1 | $510K | Sell |
17,718
-9,473
| -35% | -$272K | ﹤0.01% | 1657 |
|
|
2023
Q4 | $892K | Sell |
27,191
-7,637
| -22% | -$251K | 0.01% | 1188 |
|
|
2023
Q3 | $970K | Buy |
34,828
+4,491
| +15% | +$125K | 0.01% | 1011 |
|
|
2023
Q2 | $1.03M | Buy |
30,337
+3,254
| +12% | +$111K | 0.01% | 962 |
|
|
2023
Q1 | $814K | Sell |
27,083
-4,080
| -13% | -$123K | 0.01% | 1044 |
|
|
2022
Q4 | $880K | Sell |
31,163
-4,593
| -13% | -$130K | 0.01% | 1114 |
|
|
2022
Q3 | $1.18M | Sell |
35,756
-5,564
| -13% | -$183K | 0.01% | 896 |
|
|
2022
Q2 | $1.3M | Sell |
41,320
-4,873
| -11% | -$153K | 0.01% | 849 |
|
|
2022
Q1 | $2.12M | Sell |
46,193
-7,222
| -14% | -$332K | 0.02% | 653 |
|
|
2021
Q4 | $3.27M | Sell |
53,415
-12,870
| -19% | -$788K | 0.03% | 510 |
|
|
2021
Q3 | $4.95M | Sell |
66,285
-2,061
| -3% | -$154K | 0.05% | 391 |
|
|
2021
Q2 | $6.32M | Buy |
68,346
+1,829
| +3% | +$169K | 0.07% | 306 |
|
|
2021
Q1 | $5.9M | Buy |
66,517
+8,825
| +15% | +$783K | 0.07% | 293 |
|
|
2020
Q4 | $5.54M | Buy |
57,692
+36,507
| +172% | +$3.51M | 0.06% | 309 |
|
|
2020
Q3 | $1.35M | Buy |
+21,185
| New | +$1.35M | 0.03% | 538 |
|